"It was the best of the times, it was the worst of times..."
Our understanding of breast cancer is being transformed
Pharma's incurring bigger and more frequent financial penalties in the US
Healthcare's consuming a larger share of GDP in rich and poor countries alike
Our interactive graphic allows you to view and compare data for each country mentioned in the report and to compare any six of them.
Video: Do pharmaceutical companies have the organisational structure that allows for transformation?
Video: How can companies address the managerial challenges of the future?
Video: How can companies address the scientific challenges of the future?
Video: What do pharmaceutical companies need to do differently to continue to be successful?
Video: What should companies take into account when considering business into the BRIC countries?